...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Liquidity

ToInv..."KBC your reply got me thinking about another of Don's Comments from the AGM (based on masila's notes).

"Regarding the IPO on Nasdaq, I’ve said in the past I would never do another TSX listing – well, I’m looking at a TSX listing. One reason is that some resource companies that are not faring too well. I’m thinking that we might do a reverse takeover of one of these companies who might already have a Nasdaq listing. We’re still working on these angles to determine how viable that would be. My lawyer hasn’t even heard about this."

That's just their particular lawyer I think. Reverse takeovers are common.

BNN: Why companies choose the reverse takeover route

Fri, Jun 26, 2015 - 10:10 AM
So far this year, 11% of new listings filed on the TSX Venture have debuted through a reverse takeover. RTOs have been viewed as a cost-effective option for early-stage companies. BNN analyzes the advantages and challenges of RTOs from a legal point-of-view with Krisztián Tóth, Partner, Fasken Martineau. Why do companies take the RTO route?"

http://www.bnn.ca/Video/player.aspx?vid=644583

Hard to know what will happen or when regarding an IPO or public listing, Canada or US. I'm sure Don will figure out what makes the most sense.

Share
New Message
Please login to post a reply